Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex

详细信息    查看全文

• 作者：Jeng-Dau Tsai ; Chang-Ching Wei ; Teng-Fu Tsao ; Yu-Ping Hsiao…
• 关键词：Tuberous sclerosis complex ; Subependymal giant cell astrocytoma ; Neuroimaging ; Magnetic resonance imaging
• 刊名：Child's Nervous System
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：32
• 期：1
• 页码：89-95
• 全文大小：491 KB
• 参考文献：1.Rieger E, Kerl H (1992) The clinical spectrum of organ manifestations of tuberous sclerosis. Hautarzt 43(5):272–277PubMed
  2.Tan TK, Chen FL, Sheu JN, Chen SM, Huang HH, Tsai JD (2014) Tuberous sclerosis complex associated with heterotopic ossification in a young girl. Pediatr Neonatol 55(1):65–77CrossRef PubMed
  3.Tsai JD, Wei CC, Chen SM, Lue KH, Sheu JN (2014) Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex. Int Urol Nephrol 46(9):1685–1690CrossRef PubMed
  4.Jay V (1999) Historical contributions to pediatric pathology: legacy of Dr. Ewing. Pediatr Dev Pathol 2(6):597–599CrossRef PubMed
  5.Staley BA, Vail EA, Thiele EA (2011) Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics 127(1):e117–125CrossRef PubMedCentral PubMed
  6.Franz DN, Bissler JJ, McCormack FX (2010) Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics 41(5):199–208CrossRef PubMedCentral PubMed
  7.Christophe C, Sékhara T, Rypens F, Ziereisen F, Christiaens F, Dan B (2000) MRI spectrum of cortical malformations in tuberous sclerosis complex. Brain Dev 22(8):487–493CrossRef PubMed
  8.Hallett L, Foster T, Liu Z, Blieden M, Valentim J (2011) Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 27(8):157–183CrossRef
  9.Rosser T, Panigrahy A, McClintock W (2006) The diverse clinical manifestations of tuberous sclerosis complex: a review. Semin Pediatr Neurol 13(1):27–36CrossRef PubMed
  10.Roach ES, Sparagana SP (2004) Diagnosis of tuberous sclerosis complex. J Child Neurol 19(9):643–649PubMed
  11.Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13(12):624–628CrossRef PubMed
  12.Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group (2013) Tuberous sclerosis complex diagnostic criteria update recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 49(4):243–254CrossRef PubMedCentral PubMed
  13.Wataya-Kaneda M, Tanaka M, Hamasaki T (2013) Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS One 8(5):e63910CrossRef PubMedCentral PubMed
  14.Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49(4):255–265CrossRef PubMedCentral PubMed
  15.Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL et al (2013) Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49(6):439–444CrossRef PubMed
  16.Jóźwiak S, Nabbout R, Curatolo P (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 17(4):348–352CrossRef PubMed
  17.Rovira À, Ruiz-Falcó ML, García-Esparza E, López-Laso E, Macaya A, Málaga I et al (2014) Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. J Neurooncol 118(2):205–223CrossRef PubMed
  18.Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M (2009) Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 16(6):691–696CrossRef PubMed
  19.Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63(8):1457–1461CrossRef PubMed
  20.Roach ES, Williams DP, Laster DW (1987) Magnetic resonance imaging in tuberous sclerosis. Arch Neurol 44(3):301–303CrossRef PubMed
  21.Inoue Y, Nemoto Y, Murata R, Tashiro T, Shakudo M, Kohno K et al (1998) CT and MR imaging of cerebral tuberous sclerosis. Brain Dev 20(4):209–221CrossRef PubMed
  22.Yates JR, Maclean C, Higgins JN (2011) Tuberous Sclerosis 2000 Study Group. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child 96(11):1020–1025CrossRef PubMed
  23.Nishio S, Morioka T, Suzuki S, Kira R, Mihara F, Fukui M (2001) Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases. J Clin Neurosci 8(1):31–34CrossRef PubMed
  24.Adriaensen ME, Zonnenberg BA, de Jong PA (2014) Natural history and CT scan follow-up of subependymal giant cell tumors in tuberous sclerosis complex patients. J Clin Neurosci 21(6):939–941CrossRef PubMed
  25.Altman NR, Purser RK, Post MJ (1988) Tuberous sclerosis: characteristics at CT and MR imaging. Radiology 167(2):527–532CrossRef PubMed
  26.Kotulska K, Józwiak S (2012) Subependymal giant cell astrocytoma: role of mTOR pathway and its inhibitors. In: Hayat MA (ed) Tumors of the central nervous system, vol 5. Springer, New York, pp 45–56
  
• 作者单位：Jeng-Dau Tsai (1) (2)
  Chang-Ching Wei (3) (4)
  Teng-Fu Tsao (1) (5)
  Yu-Ping Hsiao (1) (6)
  Henry J. Tsai (7)
  Sheng-Hui Yang (8)
  Min-Ling Tsai (1) (9)
  Ji-Nan Sheu (1) (2)
  
  1. School of Medicine, Chung Shan Medical University, No. 110, Section 1, Jianguo North Road, Taichung, 402, Taiwan
  2. Department of Pediatrics, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road, Taichung, 402, Taiwan
  3. Children’s Hospital, China Medical University Hospital, Taichung, Taiwan
  4. School of Medicine, China Medical University, Taichung, Taiwan
  5. Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan
  6. Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan
  7. Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan
  8. Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan
  9. Department of Pharmacy, Chung Shan Medical University Hospital, Taichung, Taiwan
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurosurgery
  Neurosciences
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0350

文摘

Purpose The most common neurological complications associated with tuberous sclerosis complex (TSC) include intractable seizures that begin in infancy and subependymal giant cell astrocytoma (SEGA) complicated by hydrocephalus with increasing age. Information on SEGA growth of TSC patients is limited. This study aimed to examine the TSC-SEGA growth rates by periodic neuroimaging.